All terms in MeSH

Label Id Description
Mustard Compounds D02.455.526.728
Mediastinoscopes D020707 [Endoscopes for examining tissue of the anterior superior mediastinum. ]
Thoracoscopes D020708 [Endoscopes for examining the pleural cavity. ]
Toxicity Tests, Acute E05.940.790
Proxy D019727 [A person authorized to decide or act for another person, for example, a person having durable power of attorney. ]
Polylactic Acid-Polyglycolic Acid Copolymer D05.750.728.780.500
Polyglycolic Acid D05.750.728.780
Kininogen, Low-Molecular-Weight D019728 [A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by KALLIKREINS, it forms KALLIDIN. Kallidin, in turn, is converted into BRADYKININ. (From Stedman, 25th ed) ]
Laparoscopes D020706 [ENDOSCOPES for examining the abdominal and pelvic organs in the peritoneal cavity. ]
Carbon-Oxygen Ligases D019729 [Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond. EC 6.1. ]
ras GTPase-Activating Proteins D020703 [PROTEINS that specifically activate the GTP-phosphohydrolase activity of RAS PROTEINS. ]
Laryngoscopes D020704 [Endoscopes for examining the interior of the larynx. ]
Bridged-Ring Compounds D02.455.426.100
Endoscopes D019723 [Instruments for the visual examination of interior structures of the body. There are rigid endoscopes and flexible fiberoptic endoscopes for various types of viewing in ENDOSCOPY. ]
Presumed Consent D019724 [An institutional policy of granting authority to health personnel to perform procedures on patients or to remove organs from cadavers for transplantation unless an objection is registered by family members or by the patient prior to death. This also includes emergency care of minors without prior parental consent. ]
B-Lymphocyte Subsets A11.118.637.555.567.562.200
B-Lymphocytes A11.118.637.555.567.562
Polycomb Repressive Complex 1 D12.776.664.235.800.100
Patient Self-Determination Act D019726 [The purpose of this 1990 federal act is to assure that individuals receiving health care services will be given an opportunity to participate in and direct health care decisions affecting themselves. Under this act, hospitals, health care agencies, and health maintenance organizations are responsible for developing patient information for distribution. The information must include patients' rights, advance directives, living wills, ethics committees' consultation and education functions, limited medical treatment (support/comfort care only), mental health treatment, resuscitation, restraints, surrogate decision making and transfer of care. (from JCAHO, Lexicon, 1994) ]
Proto-Oncogene Protein c-ets-2 D12.776.624.664.700.175.200